www.fdanews.com/articles/184145-compounder-missed-marks-for-sterile-drug-processing-fda-says
Compounder Missed Marks for Sterile Drug Processing, FDA Says
October 27, 2017
An Alabama compounding pharmacy fell short of several standards for sterile drug processing, the FDA said in a Form 483 inspection report.
Included among the findings at the pharmacy, Triad Rx, in Daphne, were:
- Pads or wipes used to clean an isolation area were not sterile;
- Equipment that was difficult to clean or visibly dirty was located in designated sterile areas, specifically a lyophilizer and a dehumidifier;
- Workers touched equipment or surfaces with gloved hands outside the sterile workspaces and then processed sterile products inside those workspaces without changing or sanitizing their gloves;
- Workers processing sterile products with hands, wrists, legs, hair or mouths exposed; and
- A pump used in sterile processing was not properly disinfected.